Keri E. Lunsford

RH Provider

Thumbnail

Keri E. Lunsford, M.D., Ph.D.

Specialties:
Transplant Surgery (General Surgery Board)

Interests:
Liver and Kidney Transplantation
Hepatobiliary Surgery
Liver and Biliary Resections
Advanced GI Oncology Surgery
Advanced Laparoscopic Solid Organ Surgery
General Surgery
Hepatocellular Carcinoma
Cholangiocarcinoma
Aetna, Inc.
America's Choice Provider Network (ACPN)
Cigna Healthcare
Magnacare
Clover Health Plans
Devon Health Services/ULLICO
QualCare
Horizon NJ Health
Horizon NJ Total Care (HNJH)
GHI
Medicaid
Medicare
Private Healthcare Systems
Prime Health Services, Inc.
Qual Care HMO
Qual Care PPO
Emblem Health
UHC Comm / Oxford
United Healthcare Community Plan (formerly AmeriChoice of NJ, Inc.)
HealthSmart WTC
Magnacare
University Hospital, Newark
B.S., Miami University (08/01/1991-05/30/1995)
M.D., Ph.D., The Ohio State University (08/01/1999-06/10/2007)
Residency: General Surgery, Duke University Medical Center, Durham, NC, USA (06/25/2007-06/30/2013)
Chief Resident, Duke University Medical Center, Durham, NC, USA (07/01/2012-06/30/2013)
Research Fellowship: Surgery, Duke University Medical Center, Durham, NC, USA (07/01/2010-06/30/2011)
Liver and Kidney Transplantation Hepatobiliary Surgery Liver and Biliary Resections Advanced GI Oncology Surgery Advanced Laparoscopic Solid Organ Surgery General Surgery Hepatocellular Carcinoma Cholangiocarcinoma
Locations
Provider Biography
Keri E. Lunsford MD, PhD, FACS is an Assistant Professor of Surgery and a liver transplant and hepatobiliary surgeon on faculty at Rutgers New Jersey Medical School and a member of the Center for Immunity and Inflammation. Dr. Lunsford received MD and PhD degrees from The Ohio State University as part of the Medical Scientist Training Program, and she completed general surgery residency at Duke University followed by fellowship in multi-organ abdominal transplantation and hepatobiliary surgery at the University of California, Los Angeles (UCLA). She is certified by both the American Board of Surgery and the American Society of Transplant Surgeons. Prior to joining the faculty at Rutgers, she was on faculty at Houston Methodist Hospital where she played a key role in the groundbreaking protocol for liver transplant for intrahepatic cholaniocarcinoma. Her clinical interests include liver transplant oncology, simultaneous liver kidney transplantation, and liver transplant futility. She has an active translational transplant immunology research lab. Dr. Lunsford has received funding from the Association of Women Surgeons, the NIH, the ASTS, and the NJHF for her translational research in the mechanism and impact of pre-transplant immune dysfunction in liver transplant recipient outcomes. She serves on several national and international committees and is well-published in the field of transplant surgery and transplant immunology.